“Hadrontherapy for Life” Symposium, Caen, March 10/11, 2025–Strategy for the Future–Pediatric Tumors

The symposium "Hadrontherapy for life," held in Caen, on March 10 and 11, 2025, brought together over 100 international experts of heavy ions particle therapy. Clinical aspects of current indications and future strategies were discussed. If protontherapy remains the cornerstone of current strategies dealing with pediatric malignancies, in order to better spare normal tissues from deleterious effects of radiation, heavier ions such as carbon ions could play a role in selected highly radio-resistant processes such as bone and non rhabdomyosrcomas soft tissue sarcomas. A special mention should be made to helium ions tested since 2021 in Europe that mimic protons with further ballistic selectivity. If immediate and early side effects of heavy ions look modest, long-term tolerance still needs to be carefully evaluated, including risks of carcinogenesis.

Authors

Institutions

Publication Details

Journal
International Journal of Particle Therapy
Published
2025-11-26
DOI
https://doi.org/10.1016/j.ijpt.2025.101286
Primary Topic
Radiation Therapy and Dosimetry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

“Hadrontherapy for Life” Symposium, Caen, March 10/11, 2025–Strategy for the Future–Pediatric Tumors

Semi Harrabi, Siamak Haghdoost, Tatsuya Ohno, Emily Light et al.
International Journal of Particle Therapy
Radiation Therapy and Dosimetry
article

“Hadrontherapy for Life” Symposium, Caen, March 10/11, 2025–Strategy for the Future–Pediatric Tumors

Semi Harrabi, Siamak Haghdoost, Tatsuya Ohno, Emily Light, J. Doyen, Anita Mahajan, Juliette Thariat, Shigeru Yamada, Bradford S. Hoppe, Jacques Balosso, Audrey Larnaudie, Zheng Wang, Arnold Pompoš, R. Dendale, Jean‐Louis Habrand, Anthony Vela
article en

Abstract

The symposium "Hadrontherapy for life," held in Caen, on March 10 and 11, 2025, brought together over 100 international experts of heavy ions particle therapy. Clinical aspects of current indications and future strategies were discussed. If protontherapy remains the cornerstone of current strategies dealing with pediatric malignancies, in order to better spare normal tissues from deleterious effects of radiation, heavier ions such as carbon ions could play a role in selected highly radio-resistant processes such as bone and non rhabdomyosrcomas soft tissue sarcomas. A special mention should be made to helium ions tested since 2021 in Europe that mimic protons with further ballistic selectivity. If immediate and early side effects of heavy ions look modest, long-term tolerance still needs to be carefully evaluated, including risks of carcinogenesis.

International Journal of Particle TherapyVol. 18
Mayo Clinic (US), Gunma University (JP), Heidelberg University (DE), Centre Hospitalier Universitaire de Grenoble (FR), Jacksonville College (US), University Hospital Heidelberg (DE), Centre François Baclesse (LU), National Institutes for Quantum Science and Technology (JP), Centre François Baclesse (FR), Mayo Clinic in Arizona (US), The Christie NHS Foundation Trust (GB), Mayo Clinic in Florida (US), Centre Antoine Lacassagne (FR), Institut Curie (FR), The University of Texas Southwestern Medical Center (US), Université Grenoble Alpes (FR), Université de Caen Normandie (FR)
Openalex Percentile: Top 45%
Radiation Therapy and Dosimetry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.